IMTX
Immatics N.v. Health Care Biological Products, (No Diagnostic Substances) Russell 3000
$7.20Close
$6.73 – $11.8752-week range
Nov 16, 2026Next report
Highlights
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 11 · weaker than 89% of stocks over 12 months
- Far from its high 39% below its 52-week high
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Trade setup
ATR%
6.1%
$0.44 a day · 2×ATR $6.32
RS
11 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
1.9×
vs 50-day average
Up/down volume
1.22
50 sessions
Implied move
—
no option chain · report Nov 16, 2026
Trend template · 0 of 8
Screen verdict
Not scorable — no classified balance sheet.
Last shock
Oct 2, 2026-10% in one session1.9× volumeno filing matched-5% since
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Mar 5, 2026 | Annual ↗ | — | 0d |
| Mar 27, 2025 | Annual ↗ | — | 0d |
| Mar 21, 2024 | Annual ↗ | — | 0d |
| Mar 22, 2023 | Annual ↗ | — | 0d |
| Mar 23, 2022 | Annual ↗ | — | 0d |
| Mar 30, 2021 | Annual ↗ | — | 0d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 26, 2026 | Foreign issuer report ↗ |
| Oct 23, 2026 | Foreign issuer report ↗ |
| Aug 26, 2026 | Foreign issuer report ↗ |
| Aug 18, 2026 | Foreign issuer report ↗ |
| Jun 18, 2026 | Foreign issuer report ↗ |
| Jun 2, 2026 | Foreign issuer report ↗ |
| Jun 1, 2026 | Foreign issuer report ↗ |
| May 12, 2026 | Foreign issuer report ↗ |
| Apr 21, 2026 | Foreign issuer report ↗ |
| Apr 17, 2026 | Foreign issuer report ↗ |
| Mar 5, 2026 | Foreign issuer report ↗ |
| Jan 12, 2026 | Foreign issuer report ↗ |